These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8887691

  • 21. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison.
    Levin A.
    S Afr Med J; 1974 Jan 12; 48(2):47-9. PubMed ID: 4595136
    [No Abstract] [Full Text] [Related]

  • 22. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.
    J Clin Psychiatry; 2012 Jul 12; 73(7):984-91. PubMed ID: 22901348
    [Abstract] [Full Text] [Related]

  • 23. Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
    Giedke H, Gaertner H, Breyer-Pfaff U, Rein W, Axmann D.
    Eur Arch Psychiatry Neurol Sci; 1986 Jul 12; 235(6):329-38. PubMed ID: 3527706
    [Abstract] [Full Text] [Related]

  • 24. [Psychopathologic and psychophysiologic follow-up of inpatient depressed patients with standardized treatment with clomipramine and oxaprotiline].
    Steiner B, Wolfersdorf M, Keller F, Straub R, Hole G.
    Schweiz Arch Neurol Psychiatr (1985); 1991 Jul 12; 142(3):259-69. PubMed ID: 1713352
    [Abstract] [Full Text] [Related]

  • 25. A double-blind, multicentre study of paroxetine and maprotiline in major depression.
    Schnyder U, Koller-Leiser A.
    Can J Psychiatry; 1996 May 12; 41(4):239-44. PubMed ID: 8726790
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation methods of the efficacy of an antidepressive drug].
    Tignol J.
    Encephale; 2000 Nov 12; 26 Spec No 5():67-70. PubMed ID: 11217529
    [No Abstract] [Full Text] [Related]

  • 27. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M, Wendt G, Binz U, Steiner B, Hole G.
    Pharmacopsychiatry; 1988 Jul 12; 21(4):203-7. PubMed ID: 3060885
    [Abstract] [Full Text] [Related]

  • 28. The Pisa syndrome (pleurothotonus) during antidepressant therapy.
    Suzuki T, Kurita H, Hori T, Sasaki M, Baba A, Shiraishi H, Piletz JE.
    Biol Psychiatry; 1997 Jan 15; 41(2):234-6. PubMed ID: 9018396
    [No Abstract] [Full Text] [Related]

  • 29. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA, Montgomery DB, McAuley R, Rani SJ, Roy D.
    Adv Biochem Psychopharmacol; 1982 Jan 15; 32():35-42. PubMed ID: 6211942
    [No Abstract] [Full Text] [Related]

  • 30. [Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
    Giedke H, Heimann H, Rein W.
    Rev Electroencephalogr Neurophysiol Clin; 1987 Sep 15; 17(3):279-87. PubMed ID: 3685573
    [Abstract] [Full Text] [Related]

  • 31. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A.
    Adv Biochem Psychopharmacol; 1982 Sep 15; 32():43-7. PubMed ID: 7046367
    [No Abstract] [Full Text] [Related]

  • 32. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH, Geretsegger C, Whitworth AB, Schubert H, Platz T, König P, Hinterhuber H, Fleischhacker WW.
    J Clin Psychopharmacol; 1994 Aug 15; 14(4):241-6. PubMed ID: 7962679
    [Abstract] [Full Text] [Related]

  • 33. Time course of improvement under antidepressant treatment: a survival-analytical approach.
    Stassen HH, Delini-Stula A, Angst J.
    Eur Neuropsychopharmacol; 1993 Jun 15; 3(2):127-35. PubMed ID: 8364348
    [Abstract] [Full Text] [Related]

  • 34. [Recurrence of unipolar depression and efficacy of maprotiline].
    Rouillon F, Phillips R, Serrurier D, Ansart E, Gérard MJ.
    Encephale; 1989 Jun 15; 15(6):527-34. PubMed ID: 2693074
    [Abstract] [Full Text] [Related]

  • 35. Seizures and antidepressants.
    Nakielny J.
    Br J Psychiatry; 1994 Aug 15; 165(2):272. PubMed ID: 7953051
    [No Abstract] [Full Text] [Related]

  • 36. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN, Yiptong C, Samsoon J, Schulsinger F, Fabricius J.
    Pharmacopsychiatria; 1982 Sep 15; 15(5):164-9. PubMed ID: 6757983
    [Abstract] [Full Text] [Related]

  • 37. [The antidepressive maprotiline: symposium at Hradec Kralove 26 November 1980].
    Act Nerv Super (Praha); 1982 May 15; 24(2):39-118. PubMed ID: 7102224
    [No Abstract] [Full Text] [Related]

  • 38. Antidepressants and cancer: cause for concern?
    Miller LG.
    J Clin Psychopharmacol; 1993 Feb 15; 13(1):1-2. PubMed ID: 8486814
    [No Abstract] [Full Text] [Related]

  • 39. Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy.
    Hoencamp E, Haffmans PM, Duivenvoorden H, Knegtering H, Dijken WA.
    J Affect Disord; 1994 Aug 15; 31(4):235-46. PubMed ID: 7989638
    [Abstract] [Full Text] [Related]

  • 40. The Tridimensional Personality Questionnaire in major depression.
    Joffe RT, Bagby RM, Levitt AJ, Regan JJ, Parker JD.
    Am J Psychiatry; 1993 Jun 15; 150(6):959-60. PubMed ID: 8494077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.